The global In Vitro Diagnostics Quality Control Market, valued at US$1.58 billion in 2024, stood at US$1.65 billion in 2025 ...
In this article, we will be taking a look at the 13 Most Oversold Healthcare Stocks So Far in 2025. Qiagen N.V. is one of ...
Maine Molecular Quality Controls Targets a Rapidly Growing Biotechnology Market Joan Gordon and Clark Rundell, Ph.D., know the importance of controls in clinical laboratory testing, having both worked ...
Heidi Berghäll, EQA Solutions Manager, R&D of Labquality, commented, “It is important that both pathology and molecular tests ...
Molecular diagnostics are well-established in clinical medicine. Nonetheless, the markets for these tests remain one of the most attractive growth opportunities in the in vitro diagnostics industry.
The global Molecular Diagnostics Market, valued at US$18.29 billion in 2024, stood at US$19.48 billion in 2025 and is projected to advance at ...
LONDON, GREATER LONDON, UNITED KINGDOM, September 15, 2025 /EINPresswire.com/ -- What Is The Expected Cagr For The Syndromic Multiplex Diagnostics Market Through 2025? The market size for syndromic ...
The Business Research Company’s Molecular Diagnostics For Sexually Transmitted Diseases Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 ...
SALT LAKE CITY--(BUSINESS WIRE)--Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced ...
Vector Smart™ NAM-e multiplex PCR test to provide proactive defense against mosquito populations carrying the deadly eastern equine encephalitis virus SALT LAKE CITY--(BUSINESS WIRE)-- Co-Diagnostics, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback